Alzheimer’s disease protease-containing plasma extracellular vesicles transfer to the hippocampus via the choroid plexus

Alzheimer’s disease protease-containing plasma extracellular vesicles transfer to the hippocampus via the choroid plexus

22 de March, 2022 by Susana Ferreira0
Alzheimer-2.png

Alzheimer’s disease protease-containing plasma extracellular vesicles transfer to the hippocampus via the choroid plexus

BACKGROUND
Plasma extracellular vesicles (pEV) can harbor a diverse array of factors including active proteases and the amyloid-precursor-protein (APP) cleavage product Aβ, involved in plaque formation in Alzheimer`s diseases (AD). A potential role of such vesicles in AD pathology is unexplored.

METHODS
In a case-control study of randomly selected patients with AD and other neurological diseases (n = 14), and healthy controls (n = 7), we systematically analyzed the content of pEV, using different assay systems. In addition, we determined their entry path into brain tissue, employing animal (mice) injection experiments with ex vivo generated EV that were similar to AD-pEV, followed by multi antigen analysis (MAA) of brain tissue (n = 4 per condition). The results were compared with an IHC staining of human brain tissue in a small cohort of AD patients (n = 3) and controls with no neurodegenerative diseases (n = 3).

FINDINGS
We show that pEV levels are considerably upregulated in AD patients. Besides numerous inflammatory effectors, AD-pEV contained α-, β- and γ-secretases, able to cleave APP in in target cells. In vitro generated EV with similar characteristics as AD-pEV accumulated in the choroid plexus (CP) of injected animals and reached primarily hippocampal neurons. Corroborating findings were made in human brain samples. An inhibitor of hyaluronic-acid-synthetase (HAS) blocked uploading of proteases and Hyaluronan onto EV in vitro and abolished CP targeting in animal injection experiments.

INTERPRETATION
We conclude that protease-containing pEV could be part of a communication axis between the periphery and the brain that could be become detrimental depending on pEV concentration and duration of target cell impact.

 

Jung-Hyun Lee, Christian Ostalecki, Timo Oberstein, Stefan Schierer, Elisabeth Zinser, Martin Eberhardt, et al.
© 2022 The Authors. Published by Elsevier B.V.

 

Alzheimer’s disease


Leave a Reply

Your email address will not be published. Required fields are marked *



New Breathe

WE CARE, WE CAN





New Breathe

WE CARE, WE CAN




0-800-777-2331


24/7 EMERGENCY NUMBER

Call us now if you are in a medical emergency need, we will reply swiftly and provide you with a medical aid.




2021 © New Breathe. Powered with by Goweb Agency.



2021 © New Breath. Powered with by Goweb Agency.